Trademark Details For VIDA PHARMACAL (Serial Number 90040233)

  •  Home
  •  Print
VIDA PHARMACAL
0
0
0
0
Basic Information
Serial Number  United States - USPTO 90040233
Registration Number 7391955
Mark
VIDA PHARMACAL
Filing Date Jul-07-2020
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0
Action Tags
  


  • VIDA PHARMACAL, LTD.

  • Description Of Mark:
  • Color(s) Claimed:

042Computer, scientific and legal

U.S Class(es): 100, 101

Class Status: Active

First Use: Nov-14-2023

First Use in Commerce: Nov-14-2023

044Medical, beauty and agricultural

U.S Class(es): 100, 101

Class Status: Active

First Use: Jan-10-2024

First Use in Commerce: Jan-10-2024


02.11.01



Correspondences

NameB. Aaron Schulman STITES & HARBISON
Address1800 DIAGONAL ROAD SUITE 325 ALEXANDRIA, VA 22314 UNITED STATES

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jul-10-2020NEW APPLICATION ENTERED   NWAPI
Aug-04-2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Aug-05-2020NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSCE
Oct-14-2020ASSIGNED TO EXAMINER   DOCKD
Oct-14-2020
NON-FINAL ACTION WRITTEN
  
CNRTR
Oct-14-2020NON-FINAL ACTION E-MAILED   GNRTF
Oct-14-2020
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Dec-03-2020TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Dec-03-2020CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Dec-03-2020TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Dec-23-2020APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Jan-13-2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Feb-02-2021PUBLISHED FOR OPPOSITION   PUBOA
Feb-02-2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Mar-30-2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Sep-28-2021SOU TEAS EXTENSION RECEIVED   EEXTI
Sep-28-2021SOU EXTENSION 1 FILED   EXT1S
Sep-28-2021SOU EXTENSION 1 GRANTED   EX1GS
Sep-30-2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Mar-15-2022SOU TEAS EXTENSION RECEIVED   EEXTI
Mar-15-2022SOU EXTENSION 2 FILED   EXT2S
Mar-15-2022SOU EXTENSION 2 GRANTED   EX2GS
Mar-17-2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Sep-27-2022SOU TEAS EXTENSION RECEIVED   EEXTI
Sep-27-2022SOU EXTENSION 3 FILED   EXT3S
Sep-27-2022SOU EXTENSION 3 GRANTED   EX3GS
Sep-29-2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Mar-30-2023SOU TEAS EXTENSION RECEIVED   EEXTI
Mar-30-2023SOU EXTENSION 4 FILED   EXT4S
Mar-30-2023SOU EXTENSION 4 GRANTED   EX4GS
Apr-01-2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Sep-29-2023SOU TEAS EXTENSION RECEIVED   EEXTI
Oct-10-2023CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Sep-29-2023SOU EXTENSION 5 FILED   EXT5S
Oct-10-2023SOU EXTENSION 5 GRANTED   EX5GS
Oct-11-2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Mar-29-2024TEAS STATEMENT OF USE RECEIVED   EISUI
Mar-29-2024USE AMENDMENT FILED   IUAFS
Apr-01-2024STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Apr-18-2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Apr-18-2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
May-21-2024REGISTERED-PRINCIPAL REGISTER   R.PRA
May-21-2024NOTICE OF REGISTRATION CONFIRMATION EMAILED   NRCCE